SIRT6 knockout MM cell lines downregulate the transcription of DNA-damaged genes, thus enhancing anti-MM activities and proving that SIRT6 is a good candidate for MM therapeutic target [92]. This evidence concerns the gene SIRT6 and Miyoshi myopathy.